Below is a summary assembled by the Research & Innovation Office (RIO). Please see the Tang Prize website for complete information. The Tang Prize comprises four categories, namely Sustainable ...

Multifidelity optimization can inform decision-making during process development and reduce the number of experiments ...

Safety and efficacy of two candidates are currently being assessed in investigator-initiated clinical trials. BRC is planning to commence enrollment for Phase 2 and 3 trials by mid 2026. MONTEREY, ...

DURHAM, N.C. & CARLSBAD, Calif.--(BUSINESS WIRE)--KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and cGMP contract development and manufacturing organization (CDMO), and Argonaut Manufacturing ...

SOUTH SAN FRANCISCO, Calif. & PARIS--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT), a global diagnostics company, and Gustave Roussy, a leading cancer center worldwide, announced today that they have ...

Roy W. Ware, PhD, MBA appointed as Chief Manufacturing and Technology OfficerCaryn Barnett appointed as VP, Clinical ...

In process monitoring is important for optimizing cell culture conditions such as nutrient concentrations, cell viability, and metabolite production as well as product quality attributes such as ...

Solubility is fundamental in successfully developing all classes of therapeutic biopolymers. Contact with stressors related to mechanical stirring or changes in buffer conditions may cause ...

The drug development process is driven by both medical need and business opportunity. The process itself is arduous, expensive and time-consuming. Invariably, it takes not only expertise, but robust ...

AsymBio, a subsidiary of Asymchem Group (stock code: 002821.SZ / 6821.HK), announced that it has established integrated technology platforms spanning ...

ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract 75N93023D00009 ...

JUPITER, Fla., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (DYAI), a global biotechnology company announced it has signed a fully funded evaluation agreement including commercial ...